NASDAQ · Medical - Healthcare Information Services

MGRX (MGRX) Stock

$0.54 +4.28% NASDAQ: MGRX Healthcare

Valuation

MetricValue
Price$0.54
Market Cap$5.50M
P/E Ratio-0.18
P/B Ratio0.47
P/S Ratio9.12
EPS (TTM)$-2.05
52-Week High$2.75
52-Week Low$0.16
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-113.90%
ROA-60.60%
ROCE-126.67%
Gross Margin52.42%
Operating Margin-42.04%
Net Margin-46.33%
Debt/Equity0.02
Current Ratio2.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$1.0M$1.0M$0
Operating Profit$0$-2.0M$-9.0M$-8.0M$-19.0M
Net Profit$0$-2.0M$-9.0M$-9.0M$-21.0M
EPS$-0.02$-1.73$-8.58$-4.40$-2.05
Op Margin—-22279.7%-1260.3%-1294.4%-4200.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$1.0M$1.0M$15.0M$16.0M
Total Liabilities$0$0$0$1.0M$1.0M
Cash$0$1.0M$1.0M$0$1.0M
Borrowings$0$0$0$0$0

Latest News

Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology GlobeNewswire · Jul 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$-1.0M$-7.0M$-5.0M$-6.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$1.0M$1.0M$1.0M
Net Cash Flow$0$1.0M$0$-1.0M$1.0M
Free Cash Flow$0$-1.0M$-7.0M$-5.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-0.39
FCF Yield-129.28%
Quick Ratio0.29
Interest Coverage—
Return 1Y-74.52%
Return 3Y-98.51%
Return 5Y—

Ownership

Insiders Held10.04%
Institutions Held4.97%
Institutions Float Held5.53%
Institutional HolderSharesReport Date
Geode Capital Management, LLC194,4822026-03-31
Ikarian Capital, LLC138,1462026-03-31
Vanguard Capital Management LLC123,0412026-03-31
Jane Street Group, LLC72,7462026-03-31
Virtu Financial LLC61,0282026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ASBP $7.26 +3.13% -0.74 $837601 0.00%
CASICASI Pharmaceuticals, Inc. $0.15 +3.08% -0.07 $2.33M 0.00%
CING $4.52 -2.59% -1.08 $25.34M 0.00%
CLSDClearside Biomedical, Inc. $0.41 +0.00% -0.11 $2.15M 0.00%
ENTOEntero Therapeutics, Inc. $2.85 -5.00% -0.82 $13.58M 0.00%

About MGRX

MGRX is led by CEO Jacob D. Cohen, employs 3 people, headquartered in US, publicly traded since 2023.

MGRX stock trades at $0.54 with a market capitalization of $5.50M. The stock is valued at a price-to-earnings (P/E) ratio of -0.18, price-to-book of 0.47, price-to-sales of 9.12. Over the past 52 weeks the stock has ranged between $0.16 and $2.75, and currently trades 80.4% below its 52-week high.

On profitability, MGRX generates a return on equity (ROE) of -113.90%, return on capital employed of -126.67%, an operating margin of -42.04%, a net profit margin of -46.33%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides